Death by Medicine--Gary Null et al
It is as
Ben Goldacre repeated states with the results of bad pharma, “People are harmed”.
The article below documents the amount of
harm, and I can assure you that these figures could easily be multiplied by
2. For it is not just bad drugs not
worth the side effects, but that the better drugs are not taken. An ideal system
would have that information
with incentives available to physicians and the public in easy to access
form.
http://www.whale.to/a/null9.html
For a
non-technical explanation as to how pharma has worked the health system which
explains why physicians have become their foot soldiers--http://healthfully.org/rep/id11.html.
Death by Allopathy
Death by Medicine
By
Gary Null, Ph.D.,
PhD; Carolyn Dean MD,
ND; Martin Feldman, MD; Debora Rasio, MD; and Dorothy Smith,
PhD
[back] Extracts
ABSTRACT
Table 1: Estimated
Annual Mortality and Economic
Cost of Medical Intervention Table
2: Estimated
Annual Mortality and Economic Cost of Medical Intervention
Table 3:
Estimated 10-Year Death Rates from Medical Intervention
Table 4: Estimated 10-Year Unnecessary Medical Events
INTRODUCTION
Is American Medicine Working?
Underreporting
of Iatrogenic Events
Medical Ethics and Conflict
of Interest in Scientific
Medicine THE FIRST IATROGENIC
STUDY
ONLY A FRACTION
OF MEDICAL ERRORS ARE
REPORTED PUBLIC SUGGESTIONS ON IATROGENESIS
DRUG IATROGENESIS Medication Errors
Recent Adverse Drug Reactions Medicating Our Feelings Television Diagnosis
How Do We Know Drugs Are
Safe? Specific Drug Iatrogenesis: Antibiotics
The Problem
with Antibiotics
Cesarean Section
NEVER ENOUGH STUDIES
ADVERSE DRUG REACTIONS
BEDSORES
MALNUTRITION IN NURSING HOMES
Nosocomial Infections
Outpatient Iatrogenesis Unnecessary Surgeries
MEDICAL ERRORS: A GLOBAL ISSUE HEALTH INSURANCE
WAREHOUSING OUR ELDERS Overmedicating Seniors
WHAT REMAINS TO BE UNCOVERED
Appendix: OFFICE OF TECHNOLOGY ASSESSMENT
(OTA) General Facts
Hospitals
Health-Related Research and Development Pharmaceutical and Medical-Device Industries
Health Care Technology Assessment
Examples of Lack of Proper Management of HealthCare Treatments for Coronary
Artery Disease
Computed Tomography (CT) Magnetic Resonance Imaging (MRI) Laparoscopic Surgery
Infant Mortality
Magnetic Resonance Imaging (MRI) Laparoscopic Surgery
Infant Mortality
Screening for Breast Cancer Summary
References
Table 1: Estimated
Annual Mortality and Economic Cost of Medical Intervention
Condition
|
Deaths
|
Cost
|
Author
|
Adverse Drug Reactions
|
106,000
|
$12 billion
|
Lazarou(1), Suh (49)
|
Medical error
|
98,000
|
$2 billion
|
IOM(6)
|
Bedsores
|
115,000
|
$55 billion
|
Xakellis(7),
Barczak (8)
|
Infection
|
88,000
|
$5 billion
|
Weinstein(9), MMWR (10)
|
Malnutrition
|
108,800
|
-----------
|
Nurses Coalition(11)
|
Outpatients
|
199,000
|
$77 billion
|
Starfield(12), Weingart(112)
|
Unnecessary Procedures
|
37,136
|
$122 billion
|
HCUP(3,13)
|
Surgery-Related
|
32,000
|
$9 billion
|
AHRQ(85)
|
Total
|
783,936
|
$282 billion
|
|
Using Leape's 1997 medical and drug error rate
of 3 million(14) multiplied by the 14% fatality rate
he used in
1994(16) produces an annual death rate of 420,000
for drug errors and medical
errors combined. Using this number instead of Lazorou's 106,000
drug errors and the Institute of Medicine 's (IOM) estimated
98,000 annual medical errors
would add another 216,000 deaths, for a total
of 999,936
deaths annually.
Table 2: Estimated
Annual Mortality and Economic Cost of Medical Intervention
Condition
|
Deaths
|
Cost
|
Author
|
ADR/med error
|
420,000
|
$200 billion
|
Leape(14)
|
Bedsores
|
115,000
|
$55 billion
|
Xakellis(7),
Barczak (8)
|
Infection
|
88,000
|
$5 billion
|
Weinstein(9), MMWR (10)
|
Malnutrition
|
108,800
|
-----------
|
Nurses Coalition(11)
|
Outpatients
|
199,000
|
$77 billion
|
Starfield(12), Weingart(112)
|
Unnecessary Procedures
|
37,136
|
$122 billion
|
HCUP(3,13)
|
Surgery-Related
|
32,000
|
$9 billion
|
AHRQ(85)
|
Total
|
999,936
|
|
|
The enumerating of unnecessary
medical events is very important in our analysis.
Any invasive, unnecessary medical procedure must be considered as part of the
larger iatrogenic
picture. Unfortunately, cause and effect go
unmonitored. The figures on unnecessary events represent people who are thrust into a dangerous
health care system. Each
of these:
16.4
million lives is being affected
in ways that could have fatal consequences.
Simply entering a hospital could result
in the following:
In 16.4 million people, a 2.1% chance (affecting 186,000) of a serious adverse drug reaction(1)
In 16.4 million people, a 5-6% chance (affecting 489,500) of acquiring
a nosocomial infection(9)
In16.4 million people, a 4-36% chance (affecting 1.78
million) of having an iatrogenic injury (medical
error and
adverse drug reactions).(16)
In 16.4 million people, a 17% chance (affecting 1.3 million) of a procedure
error.(40)
These statistics represent a one-year time span. Working with the most conservative figures from our statistics, we project the following 10-year death rates.
Table 3: Estimated
10-Year Death Rates from Medical Intervention
Condition
10-Year D
|
eaths
Author
|
Adverse
Drug Reaction
1.06
million
|
(1)
|
Medical
error
0.98
million
|
(6)
|
Bedsores
1.15
million
|
(7,8)
|
Nosocomial
Infection
0.88
million
|
(9,10)
|
Malnutrition
1.09
million
|
(11)
|
Outpatients
1.99 million
|
(12, 112)
|
Unnecessary Procedures
371,360
|
(3,13)
|
Surgery-related
320,000
|
(85)
|
Total
7,841,360
|
|
Our
estimated 10-year total of 7.8
million iatrogenic deaths is more than all
the casualties from all the wars fought by the US throughout
its entire history.
Our projected figures for unnecessary medical events occurring
over a 10-year period also are dramatic.
Table 4: Estimated
10-Year Unnecessary Medical Events
Unnecessary Events
|
10-year Number
|
Iatrogenic Events
|
Hospitalization
|
89 million(4)
|
17 million
|
Procedures
|
75 million(3)
|
15 million
|
Total
|
164 million
|
|
These figures show that
an
estimated 164 million people—more than half of the total US population—receive unneeded medical treatment over the course of a
decade.
INTRODUCTION
Never before have the complete statistics on the multiple causes of iatrogenesis been combined in one article. Medical science amasses tens of thousands
of papers annually, each representing a tiny fragment
of the whole picture. To look
at only one piece and try to understand the benefits and risks is
like
standing an inch away from an elephant
and trying to describe everything about it. You have to step
back to see the big picture, as we
have done here. Each
specialty,
each division of medicine
keeps its own records and data on morbidity and mortality. We have now completed the painstaking work of reviewing thousands of studies and putting pieces
of the puzzle together.
Is American Medicine
Working?
US
health care spending
reached $1.6 trillion in 2003,
representing 14% of the nation's
gross national product.(15) Considering this enormous expenditure, we should have the best
medicine in the world. We should be preventing and reversing disease, and doing minimal harm. Careful and objective review, however,
shows we are doing the opposite.
Because of the extraordinarily narrow,
technologically driven context in which
contemporary medicine examines the human
condition, we are completely missing
the larger picture.
Medicine is not taking into consideration the following
critically important aspects of a
healthy human organism:
(a) stress and how it adversely
affects the immune system and life processes;
(b) insufficient exercise;
(c) excessive caloric intake; (d) highly processed
and denatured foods grown in denatured and chemically damaged soil; and (e) exposure to
tens of thousands of environmental toxins. Instead of minimizing these disease-causing factors,
we cause more illness
through medical technology, diagnostic testing, overuse of medical and surgical
procedures, and overuse of
pharmaceutical drugs. The huge disservice of this therapeutic strategy
is the result of little effort or money
being spent
on preventing disease.
Underreporting of Iatrogenic
Events
As
few as 5% and no
more than 20% of iatrogenic acts are ever reported.(16,24,25,33,34) This implies that if
medical errors were completely
and accurately reported,
we would have an annual iatrogenic death
toll much higher than
783,936. In 1994, Leape said his figure of 180,000
medical mistakes resulting in death annually was equivalent to three
jumbo-jet crashes every two days.(16) Our considerably higher figure is equivalent to six jumbo jets are falling out of
the sky each day.
What we must deduce from this report is that
medicine is in need of complete and total reform—from the curriculum
in medical schools
to protecting patients from excessive
medical intervention. It is obvious
that we cannot change anything
if we are not honest about what needs to be changed. This report simply shows the degree to which change is
required.
We
are fully aware of what stands
in the way of change: powerful pharmaceutical and medical technology companies,
along with other powerful groups with enormous
vested interests in the business
of medicine. They fund medical research, support
medical schools
and hospitals, and advertise in medical journals.
With deep pockets, they entice
scientists and academics to support their efforts. Such funding can sway the balance of opinion from professional
caution to uncritical acceptance of new therapies
and drugs. You have only to look at
the people who make up the hospital,
medical, and government health advisory boards to see conflicts of interest. The public
is mostly unaware of these interlocking interests.
For
example, a 2003 study found that nearly half of medical school faculty who serve on institutional review boards (IRB) to advise on clinical trial research also serve as consultants
to the pharmaceutical industry.(17) The study authors were concerned that such
representation could cause potential
conflicts of interest. A news release by Dr. Erik
Campbell, the lead author, said, "Our previous
research with faculty has shown
us that ties
to industry can affect
scientific behavior, leading to such things as trade secrecy and delays in publishing
research. It's possible that
similar
relationships with companies
could affect IRB members' activities and attitudes.”(18)
Medical Ethics and Conflict of Interest in Scientific Medicine
Jonathan Quick, director of essential drugs and medicines
policy for the World Health Organization (WHO), wrote in a
recent WHO bulletin: "If clinical
trials become a commercial venture in which self-interest
overrules public interest and desire overrules science,
then the social contract which allows research
on human subjects in return for medical
advances is broken."(19)
As former editor of the New England Journal of Medicine
, Dr. Marcia Angell struggled to bring greater
attention to
the
problem of commercializing scientific research. In her outgoing
editorial entitled “ Is Academic Medicine for Sale?
”
Angell said that growing conflicts of interest
are tainting science and called for stronger
restrictions on pharmaceutical stock ownership and other financial incentives
for researchers:(20) “When the boundaries between industry
and academic medicine
become as blurred as they are now, the business
goals of industry influence the mission of medical schools in multiple ways.” She did
not discount the benefits of research but said
a Faustian bargain now existed between medical schools
and the pharmaceutical industry.
Angell left the New England Journal in June 2000. In June 2002,
the
New England Journal of Medicine announced that it would accept journalists who accept money from drug companies
because it was too difficult
to find ones who have no ties. Another former editor of the journal,
Dr. Jerome Kassirer,
said that was not the case and that plenty of researchers are available who do
not work for drug companies.(21) According
to an ABC news report, pharmaceutical
companies spend over $2 billion a year on over 314,000
events attended by doctors.
The
ABC news report also noted that
a survey of clinical trials revealed
that when a drug company funds a study, there
is a
90% chance that the
drug will be perceived as effective
whereas a non-drug-company-funded study will show
favorable results only 50% of the time. It appears that
money can't buy you love but it can buy any "scientific" result desired.
Cynthia Crossen, a staffer for the
Wall Street Journal, i n
1996 published Tainted Truth : The Manipulation of Fact in America
, a book about the widespread practice
of lying with statistics.(22) Commenting on the state of scientific
research, she wrote: “The road to hell
was paved with the flood of corporate
research dollars that eagerly filled gaps left by slashed
government research funding.”
Her data on financial
involvement showed that in l981 the drug
industry
“gave” $292 million to colleges and universities for research. By l991, this figure had risen to $2.1
billion.
THE FIRST IATROGENIC STUDY
Dr.
Lucian L. Leape opened medicine's
Pandora's box in his 1994
paper, “Error in Medicine,” which
appeared in the
Journal
of the American Medical Association (JAMA).(16) He
found that Schimmel reported in 1964 that 20% of hospital patients suffered
iatrogenic injury, with a 20% fatality rate.
In 1981 Steel reported that 36% of hospitalized patients experienced iatrogenesis
with a 25% fatality rate,
and adverse drug reactions were involved
in 50% of the injuries. In 1991, Bedell
reported that 64% of acute heart attacks in one hospital
were preventable and were mostly due
to adverse drug reactions.
Leape focused on the “Harvard
Medical Practice Study” published in 1991,
(16a) which found a 4% iatrogenic
injury rate for patients, with a 14%
fatality rate, in 1984
in New York State. From the 98,609
patients injured and the 14% fatality rate,
he estimated that in the entire U.S. 180,000 people die each year partly as a
result of iatrogenic injury.
Why
Leape chose to use the much lower figure of 4% injury for his
analysis remains
in question. Using instead the average of the rates found in the three studies he cites (36%, 20%, and 4%)
would have
produced a 20% medical error rate. The
number of iatrogenic deaths using an
average rate
of injury and his 14% fatality rate would be 1,189,576.
Leape acknowledged that the literature on medical errors is sparse
and represents only the tip of the iceberg, noting that
when errors are specifically sought out, reported rates are “distressingly
high.” He cited several autopsy studies with rates
as high as 35-40% of missed diagnoses causing death. He also noted that
an intensive care unit reported
an average of 1.7 errors
per day per patient, and 29% of those
errors were potentially serious or fatal.
Leape calculated the error rate
in the intensive care unit study. First, he found that
each patient had an average of 178 “activities” (staff/procedure/medical
interactions) a day, of which 1.7
were errors, which means a 1% failure rate.
This may not seem like much, but Leape cited industry standards
showing that in aviation,
a 0.1% failure rate would mean
two unsafe plane landings
per day at Chicago's O'Hare International Airport;
in the US Postal Service, a 0.1% failure rate would
mean 16,000 pieces of lost mail every hour; and in
the banking industry,
a 0.1% failure rate would mean
32,000 bank checks deducted from the wrong bank account.
In
trying to determine why there are so many medical errors, Leape acknowledged the lack of reporting of medical
errors. Medical errors occur in thousands
of different locations and are perceived as isolated and unusual events. But
the most important reason that the
problem of medical errors is unrecognized and growing, according
to Leape, is that
doctors and nurses are unequipped to deal with human error because of the
culture of medical training and practice.
Doctors are taught that mistakes
are unacceptable. Medical mistakes
are therefore viewed as a failure of character and any error equals negligence. No one is taught
what to do when medical errors do
occur. Leape cites McIntyre and
Popper, who said the “infallibility model” of medicine
leads to intellectual dishonesty with a need to cover up
mistakes rather than admit them.
There are no Grand Rounds on
medical errors, no sharing
of failures among doctors,
and no
one
to support them emotionally when their error harms a patient.
Leape hoped his paper would
encourage medical practitioners “to fundamentally change the way they think about errors and why they occur.” It has been almost a decade since this groundbreaking work, but
the mistakes
continue to soar.
In 1995, a JAMA
report noted, "Over a million patients
are injured in US hospitals
each year, and approximately
280,000 die annually as a result of these injuries. Therefore,
the iatrogenic death rate
dwarfs the annual automobile accident mortality
rate of 45,000 and
accounts for more deaths than all other
accidents combined."(23)
At a 1997 press conference, Leape released a nationwide poll on
patient iatrogenesis conducted
by the National Patient Safety Foundation (NPSF), which is sponsored
by the American Medical Association (AMA).
Leape is a founding member of NPSF. The survey found that
more than 100 million Americans have been affected
directly or indirectly
by a medical mistake.
Forty-two percent were affected
directly and 84% personally knew of someone who had experienced a medical mistake.(14)
At this press conference, Leape updated his 1994
statistics, noting that as of 1997, medical errors in inpatient
hospital settings nationwide could be as
high as 3
million and could cost as much as $200
billion . Leape used a 14% fatality
rate to determine a medical
error death rate of 180,000
in 1994.(16) In 1997, using Leape's base number of 3 million errors, the annual death rate
could be as high as 420,000
for hospital inpatients alone.
ONLY A FRACTION
OF MEDICAL ERRORS
ARE REPORTED
In
1994, Leape said he was well aware that medical errors were not being reported.(16) A study
conducted
in two obstetrical units in the
UK found that
only about one-quarter of adverse incidents were ever reported,
to protect staff, preserve reputations, or for fear of reprisals, including
lawsuits.(24). An analysis by Wald
and Shojania found that
only 1.5% of all adverse events result in an incident
report, and only 6% of adverse drug events are identified properly.
The authors learned that the
American College of Surgeons estimates
that surgical incident reports routinely capture only 5-30% of adverse events. In one study, only 20% of surgical complications resulted in discussion
at morbidity
and
mortality rounds.(25) From these studies, it appears that all the statistics gathered on medical
errors may substantially underestimate the number of adverse drug and medical
therapy incidents. They also suggest
that our statistics concerning mortality
resulting from medical errors may be
in fact be conservative figures.
An
article in Psychiatric Times (April
2000) outlines the stakes involved in reporting medical errors.(26) The authors
found that the public is fearful of suffering a fatal
medical error, and doctors are afraid they will be sued if they report an
error. This brings up the obvious question: who is reporting
medical errors? Usually it is the patient or the patient's
surviving family. If no one notices the error, it is never reported. Janet Heinrich,
an associate director at the U.S.
General Accounting Office responsible for health financing
and public health issues, testified before a House subcommittee hearing
on medical errors that "the full magnitude of their threat to the
American public is
unknown”
and
"gathering valid and useful information about adverse events is extremely
difficult." She acknowledged that
the fear of being blamed, and the potential for legal liability, played key roles in the underreporting of errors. The Psychiatric Times noted that the
AMA strongly opposes mandatory reporting
of medical errors.(26) If doctors are not
reporting, what about nurses? A survey of nurses found that they
also fail to report medical mistakes
for fear of retaliation.(27)
Standard medical pharmacology texts admit that relatively few doctors ever report adverse drug reactions to the
FDA. (28) The reasons
range from not knowing such a reporting system exists to fear of being sued.(29) Yet the
public depends on this tremendously flawed system of voluntary reporting
by doctors to know whether a drug or a
medical intervention is harmful.
Pharmacology texts also will tell doctors how hard it is to
separate
drug side effects
from disease symptoms.
Treatment failure is most often attributed
to the disease and not the drug or
doctor. Doctors are warned, “Probably
nowhere else
in
professional life are mistakes
so easily hidden, even from ourselves.”(30) It may be hard to accept, but it is not difficult to understand why only
1 in 20
side effects is reported to either hospital
administrators or the FDA. (31, 31a)
If hospitals
admitted to the actual number of
errors for which they are responsible, which is
about 20
times what is reported, they would come under intense scrutiny.(32) Jerry Phillips,
associate director of the FDA's Office of Post
Marketing Drug Risk Assessment, confirms
this number. “In the broader area of adverse drug reaction data, the
250,000 reports received annually probably
represent only 5% of the actual reactions
that occur.”(33) Dr. Jay Cohen, who
has extensively researched
adverse drug reactions,
notes that because only 5% of
adverse drug reactions are reported, there are in fact 5 million medication reactions each year.(34)
A
2003 survey is all the
more distressing because there
seems to be no improvement in error reporting,
even with all the attention
given to this topic. Dr. Dorothea
Wild surveyed medical residents
at a community hospital in Connecticut
and found that only half were aware that the
hospital had a medical error-reporting
system, and that the
vast majority did not use it
at all. Dr.
Wild says this does not bode
well for the future. If doctors
don't learn error reporting
in their training, they will never use it. Wild
adds that error reporting is the first step in
locating
the gaps in the medical
system and fixing them. Not
even that first step has been taken to date.(35)
PUBLIC SUGGESTIONS ON IATROGENESIS
In
a telephone survey, 1,207
adults ranked the effectiveness of the following
measures in reducing preventable medical errors that
result in serious harm.(36) (Following each measure is the percentage of respondents who ranked the measure as “very effective.”)
giving doctors
more time to spend with patients (78%)
requiring hospitals
to develop systems
to avoid medical errors (74%)
better training
of health professionals (73%)
using only doctors specially
trained in intensive
care medicine on intensive care units (73%)
requiring hospitals
to report all serious medical errors to a state agency (71%)
increasing the number of hospital nurses (69%)
reducing
the work hours of doctors in training
to avoid fatigue (66%)
encouraging hospitals
to voluntarily report serious medical errors to a state agency (62%).
DRUG IATROGENESIS
Prescription drugs constitute the major treatment
modality of scientific
medicine. With the discovery
of the “germ theory,”
medical scientists convinced
the public that infectious organisms
were the cause of illness.
Finding the “cure”
for these infections proved much harder than anyone imagined. From the beginning, chemical drugs promised much more
than they delivered. But far
beyond not working, the drugs also caused incalculable side effects. The drugs
themselves, even when properly prescribed, have side effects
that can be fatal, as Lazarou's
study(1) showed. But human
error can make the situation
even worse.
Medication Errors
A
survey of a 1992
national pharmacy database found a total of 429,827
medication errors from 1,081
hospitals. Medication errors occurred
in 5.22% of patients
admitted to these hospitals
each year. The authors concluded
that at least 90,895 patients annually
were harmed by medication errors in the
US as a whole.(37)
A
2002 study shows that 20%
of hospital medications for patients had dosage errors. Nearly 40% of these errors were considered potentially harmful to the patient.
In a typical 300-patient hospital, the number of errors per day was
40.(38)
Problems involving patients' medications were even
higher the following
year. The error rate
intercepted by pharmacists in this study was 24%, making
the potential minimum number of patients
harmed by prescription drugs
417,908.(39)
Recent Adverse Drug Reactions
More-recent studies on adverse
drug reactions show that
the figures from 1994 published in Lazarou's 1998 JAMA
article may be increasing. A 2003 study followed
400 patients after discharge
from a tertiary care hospital
setting (requiring highly specialized
skills, technology, or support
services). Seventy-six patients
(19%) had adverse events.
Adverse drug events were the most common,
at 66% of all events. The next most common
event was procedure-related
injuries, at 17%.(40)
In
a New England Journal of Medicine
study, an alarming
one in four patients suffered
observable side effects
from the more than 3.34
billion prescription drugs filled in 2002.(41) One of the doctors who produced the study was interviewed
by Reuters and commented, "With these 10-minute appointments, it's hard for the doctor to get into whether the symptoms are bothering the patients."(42) William Tierney, who editorialized
on the New England Journal study,
said “… given the increasing number of powerful drugs available
to care for the aging population, the problem will only get worse.” The drugs
with the worst record of side effects
were selective serotonin reuptake
inhibitors ( SSRIs), nonsteroidal anti-inflammatory drugs (NSAIDs), and calcium-channel blockers.
Reuters also
reported that prior research has suggested that
nearly 5% of hospital admissions (over 1
million per year) are the result of
drug side effects.
But most of the cases are not documented as such. The study found that
one of the reasons for this failure
is that in nearly two-thirds of
the cases, doctors could not diagnose drug side
effects or the side effects persisted
because the doctor failed to heed the warning signs.
Medicating Our Feelings
Patients seeking a more joyful existence
and relief from worry, stress, and anxiety
often fall victim to the messages
endlessly displayed on TV and billboards. Often, instead of gaining relief, they fall victim to the
myriad iatrogenic side effects of antidepressant medication.
Moreover, a whole generation of antidepressant users has been created from young
people growing up on Ritalin. Medicating youth and
modifying their emotions must have some impact on how they learn to
deal with their feelings.
They learn to equate coping with drugs rather than with their inner resources. As adults, these medicated youth reach
for alcohol, drugs, or even street drugs to cope. According to JAMA , “Ritalin acts much like cocaine.”(43) Today's marketing of mood-modifying drugs such as Prozac and Zoloft
® makes them not only socially
acceptable but almost a
necessity in today's stressful world.
Television Diagnosis
To
reach the widest audience possible,
drug companies are no
longer just targeting medical doctors
with their marketing of antidepressants. By 1995,
drug companies had tripled the amount
of money allotted to direct advertising of prescription drugs to
consumers. The majority of this
money is spent on
seductive television ads. From 1996 to
2000, spending rose from $791
million to nearly $2.5 billion.(44) This $2.5 billion represents
only 15% of the total
pharmaceutical advertising budget.
While the drug companies maintain that direct-to-consumer advertising is educational, Dr. Sidney M. Wolfe of the Public Citizen Health Research Group in Washington, DC, argues that the
public often is misinformed about these ads.(45) People want what they see on television and are told to go to their
doctors for a prescription. Doctors in private practice either acquiesce to their patients'
demands for these drugs or spend
valuable time trying to talk patients out of unnecessary drugs. Dr. Wolfe
remarks that one important study found
that people mistakenly believe that
the “FDA reviews all ads before they are released and allows only the safest and
most effective drugs to be promoted
directly to the public.”(46)
How Do We Know Drugs Are Safe?
Another aspect of scientific medicine
that the public takes for granted
is the testing of new drugs. Drugs generally are tested on individuals
who are fairly healthy
and not on other medications that could
interfere with findings.
But when these new drugs are declared “safe” and
enter the drug prescription books, they are naturally going to be
used by people
who are on a variety of other medications and have a lot of other
health problems. Then a new
phase of drug
testing called “post-approval” comes into play, which is the
documentation of side effects
once drugs hit the market. In
one very telling report, the federal government's General Accounting Office "found that of the 198 drugs
approved by the FDA between 1976 and
1985... 102 (or 51.5%) had serious post-approval risks... the serious post-approval risks (included)
heart failure, myocardial infarction,
anaphylaxis, respiratory depression and arrest,
seizures, kidney and liver
failure, severe blood disorders, birth defects and fetal toxicity,
and blindness."(47)
NBC
Television's investigative show “Dateline” wondered
if your doctor is moonlighting as a drug
company
representative. After a yearlong
investigation, NBC reported
that because doctors can legally prescribe
any drug to any
patient for any condition, drug companies heavily promote "off
label" and frequently inappropriate and untested
uses of these medications, even though these drugs are approved only for the specific indications for which they have been tested.(48)
The
leading causes of adverse drug reactions are antibiotics (17%), cardiovascular drugs
(17%),
chemotherapy (15%), and analgesics and anti-inflammatory agents (15%).(49)
|
Specific Drug Iatrogenesis: Antibiotics
According to
William Agger,
MD, director of microbiology and
chief
of infectious disease at
Gundersen
Lutheran
Medical Center in
La Crosse, WI, 30
million pounds of antibiotics are
used in America each year.(50) Of this amount,
25 million pounds are
used in animal husbandry, and 23
million pounds are used to
try to prevent
disease and the stress of
shipping,
as well as to promote growth.
Only 2 million pounds are given for specific
animal infections. Dr.
Agger reminds us that low
concentrations of antibiotics are measurable
in many of our foods and
in various waterways
around the world, much of
it seeping in from animal farms.
Agger contends that overuse of
antibiotics results
in food-borne infections resistant
to antibiotics. Salmonella
is found in 20% of
ground meat, but the constant exposure
of cattle to antibiotics has
made 84% of salmonella
resistant to at
least one anti-salmonella antibiotic.
Diseased animal food accounts
for 80% of salmonellosis in
humans, or 1.4
million cases per year. The
conventional approach to countering
this epidemic is to radiate food
to try to kill all organisms while continuing to
use the antibiotics that created the
problem in the first place. Approximately
20% of chickens
are contaminated with Campylobacter jejuni, an organism
that causes 2.4 million cases of illness annually.
Fifty-four percent of
these organisms
are resistant to at least one
anti-campylobacter antimicrobial agent.
Denmark banned growth-promoting
antibiotics beginning in 1999,
which cut their use
by
more than half within a
year,
from 453,200 to 195,800 pounds. A
report from Scandinavia found that
removing antibiotic growth promoters had
no
or minimal effect on food production
costs. Agger warns that the current crowded, unsanitary
methods of animal
farming in the US
support
constant stress and infection, and
are geared toward high antibiotic use.
In
the US, over 3 million pounds of
antibiotics are used every year on humans.
With a population of 284
million Americans, this amount is
enough to give every man, woman,
and child
10 teaspoons of pure antibiotics per
year.
Agger says that exposure to a
steady stream of antibiotics has
altered pathogens
such as Streptococcus pneumoniae,
Staplococcus aureus, and entercocci, to
name a few.
Almost half
of patients with upper respiratory tract
infections in the U.S. still receive
antibiotics from their doctor.(51)
According to
the CDC, 90% of upper respiratory
infections
are viral and should not
be treated
with antibiotics. In
Germany, the prevalence of
systemic
antibiotic use in children aged
0-6 years was 42.9%.(52)
Data obtained from nine
US health insurers on antibiotic use
in 25,000 children from 1996 to 2000 found
that rates of antibiotic use decreased. Antibiotic
use in children aged three months to
under 3 years decreased 24%, from 2.46 to
1.89 antibiotic prescriptions per
patient per year. For children aged
3
to under 6 years, there was a
25% reduction
from
1.47 to 1.09 antibiotic prescriptions per
patient per year. And for children
aged 6 to under 18
years, there was a 16%
reduction from 0.85 to 0.69 antibiotic prescriptions
per patient per year.(53) Despite these reductions, the data indicate that on average every
child
in America receives 1.22
antibiotic prescriptions annually.
Group A beta-hemolytic
streptococci is the only common cause
of sore throat that
requires antibiotics, with penicillin
and erythromycin the only recommended
treatment. Ninety percent of sore-throat cases, however,
are viral. Antibiotics
were used in 73%
of the estimated
6.7 million adult annual visits for sore throat
in the US between 1989 and
1999. Furthermore, patients
treated with antibiotics were prescribed non-recommended broad-spectrum
antibiotics in 68% of
visits. This period saw
a significant increase
in the use of newer, more
expensive broad-spectrum antibiotics and
a decrease in use of the
recommended antibiotics penicillin and erythromycin.(54) Antibiotics being prescribed in 73%
of
sore-throat cases instead
of the recommended 10% resulted in
a total of 4.2 million unnecessary antibiotic
prescriptions from 1989 to 1999.
The Problem with
Antibiotics
In
September 2003, the CDC re-launched a program started in
1995 called “Get Smart: Know When Antibiotics Work.”(55) This $1.6
million campaign is designed to educate patients
about the overuse and inappropriate use of antibiotics. Most people involved with alternative medicine have known about the dangers of antibiotic
overuse for decades. Finally the government is focusing on the problem, yet it is spending only a
miniscule
amount of money on an iatrogenic
epidemic that is costing billions of dollars and thousands
of lives. The CDC warns that
90% of upper
respiratory infections, including children's
ear infections, are viral and
that
antibiotics do not treat viral infection.
More than 40% of about 50 million prescriptions
for antibiotics written each year in
physicians' offices are inappropriate.(2) Using antibiotics when not needed can lead to the development of deadly strains
of bacteria that are
resistant to drugs and
cause more than 88,000
deaths due to hospital-acquired infections.(9) The CDC,
however,
seems to be blaming
patients for misusing antibiotics even though they are
available
only by prescription from physicians. According
to Dr. Richard Besser,
head of “Get Smart”: "Programs
that have just targeted
physicians have not worked.
Direct-to- consumer advertising of drugs is to
blame in some cases.” Besser says the program “teaches patients
and the general public that
antibiotics are precious resources
that must be used correctly if we want to
have them
around when we need them.
Hopefully, as a result of this campaign,
patients will feel more
comfortable asking their doctors for the best care
for their illnesses, rather than asking for antibiotics."(56)
Cesarean Section
In
1983, 809,000 cesarean
sections (21% of live births) were performed
in the US, making
it the nation's most common obstetric-gynecologic (OB/GYN) surgical procedure. The
second most common
OB/GYN operation was hysterectomy
(673,000), followed by diagnostic dilation and
curettage
of the uterus (632,000). In
1983,
OB/GYN procedures represented 23% of
all surgery completed
in the US.(104)
In
2001, cesarean section is still the most
common OB/GYN surgical procedure.
Approximately 4 million births occur
annually, with 24% (960,000) delivered
by cesarean section. In the Netherlands, only
8% of births are delivered by cesarean
section. This suggests 640,000
unnecessary cesarean sections—entailing three to four times
higher mortality and 20
times greater morbidity
than vaginal delivery(105)—are performed
annually
in the US.
The
US cesarean rate
rose
from just 4.5% in 1965 to 24.1%
in 1986.
Sakala contends that an “uncontrolled
pandemic of medically unnecessary cesarean births
is occurring.”(106) VanHam reported a cesarean
section postpartum hemorrhage rate
of 7%, a hematoma formation
rate of 3.5%, a urinary tract infection rate of 3%, and a combined postoperative morbidity
rate of 35.7% in a high-risk population undergoing
cesarean section.(107)
NEVER ENOUGH STUDIES
Scientists claimed there were never
enough studies revealing the dangers of
DDT and other dangerous
pesticides to ban them.
They also used this argument
for tobacco, claiming
that more studies were needed before
they could be
certain that tobacco really caused lung
cancer. Even the American Medical Association
(AMA) was
complicit in suppressing the results of
tobacco research.
In 1964, when the Surgeon General's
report condemned smoking,
the AMA refused to endorse it,
claiming
a need for more research.
What they really wanted was
more money, which they received from a
consortium of tobacco companies that paid
the AMA $18
million over the next nine
years during which the AMA said nothing
about the dangers of smoking.(108)
The
Journal of
the American
Medical Association (JAMA),
"after careful consideration of
the extent to which cigarettes were
used by physicians in practice," began accepting
tobacco advertisements
and money in 1933. State journals such as
the New
York State Journal of Medicine also
began to run advertisements for Chesterfield cigarettes that claimed cigarettes
are "Just as pure as
the water you
drink… and practically untouched by human
hands." In 1948,
JAMA
argued "more can be said in
behalf of
smoking as a form of
escape from tension than against it…
there
does not seem to be
any preponderance of evidence that would indicate the abolition
of the use of tobacco as
a substance
contrary to the public health."(109) Today, scientists
continue to use the excuse that
more studies are needed before they will support
restricting the inordinate use of drugs.
ADVERSE DRUG
REACTIONS
The
Lazarou study(1) analyzed records for prescribed medications for 33
million US hospital admissions in 1994.
It discovered 2.2 million serious injuries due to prescribed drugs; 2.1% of inpatients experienced a serious adverse drug
reaction, 4.7% of all hospital admissions
were due to a serious adverse drug reaction, and fatal adverse drug reactions occurred in 0.19% of inpatients
and 0.13% of admissions. The authors estimated
that 106,000 deaths occur annually
due to adverse drug reactions.
Using a cost analysis
from a 2000
study in which the increase
in hospitalization costs
per
patient suffering an adverse
drug reaction was $5,483, costs for the
Lazarou study's
2.2 million patients with serious drug
reactions amounted
to
$12 billion.(1,49)
Serious adverse drug reactions commonly
emerge after FDA approval of the
drugs involved. The safety of new
agents
cannot be known with certainty until
a drug has been on the market
for many years.(110)
BEDSORES
Over one million people develop
bedsores in U.S. hospitals
every year. It's a tremendous burden
to patients
and family, and a $55
billion dollar healthcare burden. (7) Bedsores are preventable with proper nursing
care. It is true that
50% of those affected are in a vulnerable age group of over
70. In the elderly bedsores
carry a fourfold increase in the rate of death. The mortality rate in hospitals for patients with bedsores
is between 23% and 37%. (8) Even if
we just take the
50%
of people over 70
with bedsores and the lowest mortality
at 23%, that
gives us a death rate due
to bedsores of
115,000. Critics will say
that it was the disease or
advanced age that
killed the patient, not
the bedsore, but our
argument is that an early death, by denying
proper care, deserves
to be counted. It is
only after counting
these unnecessary deaths that we can
then turn our attention
to fixing the problem.
MALNUTRITION IN
NURSING
HOMES
The General Accounting Office
(GAO), a special investigative branch of
Congress,
cited 20% of the nation's
17,000 nursing homes
for violations between July 2000 and
January 2002. Many violations
involved serious physical injury
and
death.(111)
A
report from the Coalition for
Nursing Home Reform states that
at least one-third of the nation's 1.6 million
nursing home residents may suffer from malnutrition
and dehydration, which hastens their death.
The report calls for adequate nursing staff to
help feed patients who are not
able to manage a food tray
by
themselves.(11) It is difficult to place a mortality rate on malnutrition and dehydration. The Coalition report states that malnourished residents, compared with
well-nourished
hospitalized nursing home residents, have a
fivefold
increase in mortality
when they are admitted
to a
hospital. Multiplying the
one-third of
1.6
million nursing home residents
who are malnourished by a mortality
rate of
20%(8,14) results in 108,800 premature deaths due to malnutrition in nursing
homes.
Nosocomial Infections
The rate of nosocomial infections
per 1,000 patient days rose from 7.2
in 1975 to 9.8 in 1995, a 36%
jump in 20
years. Reports from more than 270 US
hospitals showed that
the nosocomial infection rate itself
had remained stable over
the previous 20 years, with approximately five
to six hospital-acquired infections
occurring per 100
admissions, a rate of
5-6%. Due
to progressively shorter inpatient stays
and the increasing number of
admissions, however,
the number of
infections increased. It is
estimated that in 1995,
nosocomial infections cost $4.5
billion and contributed to
more than
88,000 deaths, or one
death every 6
minutes.(9) The 2003
incidence of nosocomial mortality is quite
probably higher than in 1995
because of the tremendous increase
in antibiotic-resistant organisms.
Morbidity and Mortality
Report found that nosocomial infections cost $5 billion annually
in 1999,(10) representing a $0.5
billion increase in just four years. At
this rate of increase,
the current cost of nosocomial
infections would be around $5.5
billion.
Outpatient Iatrogenesis
In
a 2000 JAMA article,
Dr. Barbara Starfield
presents well-documented facts
that
are both shocking and
unassailable.(12) The U.S. ranks 12th of 13 industrialized countries when judged by
16 health status indicators. Japan, Sweden, and Canada were first, second, and third, respectively. More than 40 million people in the US have no
health insurance, and 20-30% of patients receive contraindicated care.
Starfield warns that one cause
of medical mistakes
is overuse of technology, which
may create a "cascade effect" leading to
still more treatment.
She urges the use of ICD
(International Classification of Diseases) codes that have designations such as
"Drugs, Medicinal,
and Biological Substances Causing Adverse Effects
in Therapeutic Use" and
"Complications of Surgical and
Medical Care" to help doctors
quantify and recognize
the magnitude of the medical error problem.
Starfield notes that
many deaths attributable to
medical error today are likely to
be coded to indicate
some other cause of
death. She
concludes that against the backdrop
of our poor health report card
compared
to other Westernized countries, we should recognize
that the harmful effects
of health care interventions account for
a substantial proportion of our excess deaths.
Starfield cites Weingart's 2000 article, “Epidemiology of
Medical Error,” as well as
other authors to suggest
that between 4% and 18%
of consecutive patients
in outpatient settings suffer an iatrogenic event leading to:
1.
116 million extra physician visits
2.
77 million extra prescriptions filled
3.
17 million emergency department
visits
4.
8 million hospitalizations
5.
3 million long-term
admissions
6.
199,000 additional deaths
7.
$77 billion in extra
costs(112)
Unnecessary Surgeries
While some 12,000 deaths occur
each year from unnecessary surgeries, results
from the few
studies that have measured unnecessary surgery directly indicate
that for some highly controversial operations, the
proportion of unwarranted surgeries could be as high
as 30%.(74)
MEDICAL ERRORS: A
GLOBAL ISSUE
A
five-country survey published
in the Journal of Health Affairs found that 18-28% of people who were
recently
ill had suffered from a medical
or drug error in the
previous two years. The study surveyed
750 recently ill adults. The
breakdown by country showed the
percentages of those suffering
a medical or drug error were
18% in Britain, 23% in Australia and
in New Zealand, 25% in
Canada, and 28% in the US.(113)
HEALTH INSURANCE
The
Institute of Medicine recently found that
the 41 million Americans with
no health
insurance have consistently
worse clinical outcomes than those
who are insured,
and are at increased risk for
dying prematurely (114).
When doctors bill for
services they do
not render, advise unnecessary tests,
or screen everyone for a
rare condition,
they are committing insurance fraud.
The US GAO estimated
that $12 billion dollars was lost to
fraudulent or unnecessary claims in 1998, and
reclaimed $480 million in judgments in
that
year. In 2001, the federal government won
or negotiated more than $1.7 billion in
judgments, settlements, and administrative impositions in
health care fraud
cases and proceedings.(115)
WAREHOUSING OUR
ELDERS
One
way to measure the moral and
ethical
fiber of a society is
by
how it treats its weakest
and most vulnerable
members. In some cultures,
elderly people lives out their lives
in extended family settings that enable them to
continue
participating in family and community
affairs. American nursing
homes, where millions of
our elders go
to live out their final days, represent
the pinnacle of social isolation
and medical abuse.
In America, approximately 1.6 million elderly
are confined to nursing
homes. By 2050, that number could be
6.6 million.(11,116)
Twenty percent of all deaths
from all causes occur in nursing homes.(117)
Hip
fractures are the single greatest reason
for nursing home admissions.(118)
Nursing homes represent a
reservoir for drug-resistant
organisms due to overuse of
antibiotics.(119)
Presenting a
report he sponsored
entitled "Abuse of Residents
is a Major Problem in
U.S. Nursing Homes" on July 30,
2001, Rep. Henry Waxman (D-CA) noted that
“as a
society we will be judged by
how we treat the
elderly." The report found one-third of the nation's
approximately 17,000 nursing
homes were cited for an
abuse violation
in a two-year period from January
1999 to January 2001.(116) According to Waxman, “the people who cared for us
deserve better."
The report suggests that this known abuse represents
only the “tip of the iceberg”
and that much more abuse occurs
that we aware of or ignore.(116a) The report found:
Over
30% of US
nursing homes were cited for abuses, totaling
more than 9,000
violations.
10% of nursing
homes had violations that caused actual
physical harm to residents
or worse.
Over
40% (3,800) of the
abuse violations followed
the filing of a formal complaint,
usually by concerned family members.
Many verbal
abuse violations were found. Occasions of
sexual abuse.
Incidents of physical abuse causing
numerous
injuries such as fractured
femur, hip, elbow, wrist,
and other injuries.
Dangerously understaffed
nursing homes lead to neglect, abuse,
overuse of medications, and physical restraints.
In
1990, Congress mandated
an exhaustive study of nurse-to-patient ratios in nursing
homes. The study was
finally begun
in 1998 and took four years
to complete.(120) A spokesperson for The
National
Citizens' Coalition for Nursing Home Reform commented on the study: “They
compiled two reports of three
volumes each thoroughly documenting the number of hours of
care residents
must receive from nurses and nursing
assistants to avoid painful, even dangerous,
conditions such as bedsores
and infections. Yet it took the Department of Health and Human Services
and Secretary Tommy Thompson
only four months to dismiss the report as ‘insufficient.'”(121) Although preventable with proper nursing
care, bedsores occur three times more commonly in nursing
homes than in acute care or veterans hospitals.(122).
Because many nursing home patients
suffer from chronic
debilitating conditions, their assumed cause
of death often is unquestioned by physicians. Some
studies show that
as many as 50%
of deaths due to restraints, falls,
suicide,
homicide, and choking in
nursing homes may be covered
up.(123,124) It is possible that many
nursing home deaths are instead attributed to heart disease. In fact,
researchers have found that heart disease may be over-represented in the general population
as a cause of death on
death certificates by 8-24%. In the elderly,
the overreporting of heart
disease
as a
cause of death is as
much as twofold.(125)
That very few statistics exist
concerning malnutrition in acute-care hospitals
and nursing homes demonstrates the lack of concern
in this area. While a
survey of the literature turns up few US studies,
one revealing
US study evaluated the
nutritional status of 837
patients in a 100-bed subacute-care hospital over
a 14-month period. The
study found only 8%
of the patients were
well nourished, while 29% were
malnourished and 63% were at
risk of malnutrition. As a result,
25%
of the malnourished patients required
readmission to an acute-care hospital,
compared to 11% of the
well- nourished patients. The authors concluded
that malnutrition reached epidemic proportions in
patients admitted to this
subacute-care facility.(126)
Many studies conclude that physical
restraints are an underreported and
preventable cause of death. Studies show
that
compared to no restraints, the use
of restraints
carries a higher mortality rate and
economic burden.(127-129) Studies have found that physical restraints, including bedrails,
are the cause of at least 1 in every 1,000 nursing-home deaths.(130-132)
Deaths caused by malnutrition, dehydration,
and physical restraints, however, are
rarely recorded
on death certificates.
Several
studies reveal that nearly half of
the listed causes of death on
death certificates for elderly people
with chronic or
multi-system disease are
inaccurate.(133) Even though 1
in 5 people die in nursing homes, an autopsy is performed
in less than 1% of these deaths.(134).
Overmedicating Seniors
Dr. Robert
Epstein, chief medical
officer
of Medco Health Solutions Inc.
(a unit of Merck & Co.), conducted
a study in
2003 of drug trends among
the elderly.(135) He found that seniors are going to multiple physicians, getting multiple
prescriptions, and using multiple pharmacies. Medco oversees drug-benefit plans for more than 60 million Americans, including 6.3
million seniors who received more than 160 million prescriptions. According to the study, the average senior receives
25
prescriptions each year. Among
those 6.3 million seniors,
a total of 7.9 million medication
alerts were triggered: less
than
one-half that number, 3.4 million,
were detected in 1999.
About 2.2 million of those alerts
indicated excessive dosages unsuitable for seniors, and about 2.4 million alerts indicated clinically inappropriate drugs for the elderly. Reuters interviewed Kasey Thompson, director of the Center on Patient Safety at the American Society of
Health System Pharmacists, who noted: “There are serious and systemic
problems with poor continuity of care in the United States .” He says this study represents only “the tip of the iceberg” of a
national
problem.
According to Drug Benefit Trends ,
the average number of
prescriptions dispensed per non-Medicare HMO
member
per year rose 5.6% from
1999
to 2000, - from 7.1 to 7.5 prescriptions. The
average number dispensed for Medicare
members increased 5.5%, from 18.1 to
19.1
prescriptions.(136) The total number of
prescriptions written in the US
in
2000 was 2.98 billion, or
10.4 prescriptions
for every man, woman, and child.(137)
In a
study of 818
residents of residential care facilities
for the elderly,
94% were receiving at least one
medication at
the
time of the interview. The
average intake of medications was
five per resident; the authors noted
that
many of these drugs were given
without a documented diagnosis
justifying their use.(138)
Seniors and groups like the American
Association for Retired
Persons (AARP) are demanding that prescription drug coverage
be a basic right.(139) They have accepted
allopathic medicine's overriding assumption that aging and dying
in
America must be accompanied by drugs
in nursing homes and eventual hospitalization. Seniors are
given the choice
of either high-cost patented drugs or
low-cost generic drugs. Drug companies
attempt to
keep the most expensive
drugs on the shelves and
suppress access to generic drugs, despite
facing
stiff fines of hundreds of
millions of dollars
levied by the federal government.(140,141) In 2001, some
of the world's largest drug companies were fined a record
$871 million for conspiring to
increase the price
of vitamins.(142)
Current AARP recommendations for
diet
and nutrition assume that seniors are
getting all the nutrition they need in
an
average diet. At most, AARP suggests adding
extra
calcium and a multivitamin and
mineral supplement.(143)
Ironically, studies also indicate
underuse of proper pain medication for
patients who need it. One study
evaluated pain management in a group of
13,625 cancer patients, aged 65 and over, living
in nursing homes. While almost 30%
of the
patients reported pain, more
than 25% received no pain relief medication,
16% received a mild analgesic
drug, 32% received a moderate analgesic
drug, and 26% received adequate pain-relieving morphine.
The authors concluded
that older patients and minority patients
were more likely to have
their pain untreated.(144)
WHAT REMAINS TO
BE UNCOVERED
Our ongoing
research
will continue to quantify the
morbidity, mortality, and financial loss due to:
1.
X-ray
exposures (mammography,
fluoroscopy, CT scans).
2.
Overuse of antibiotics for all conditions.
3.
Carcinogenic drugs (hormone
replacement therapy,*
immunosuppressive and prescription drugs).
4.
Cancer chemotherapy(70)
5. Surgery and unnecessary
surgery (cesarean section, radical mastectomy, preventive
mastectomy, radical
hysterectomy, prostatectomy, cholecystectomies, cosmetic surgery,
arthroscopy, etc.).
6.
Discredited medical procedures and therapies.
7.
Unproven medical therapies.
8.
Outpatient surgery.
9.
Doctors themselves.
* Part of our
ongoing research will be to
quantify the mortality and morbidity caused
by
hormone replacement therapy (HRT) since the
1940s. In December 2000,
a government scientific advisory panel
recommended that synthetic estrogen be added to the
nation's
list of cancer-causing agents. HRT, either synthetic estrogen
alone or combined
with synthetic progesterone, is used by an estimated
13.5 to 16
million women in the
US.(145) The aborted
Women's
Health Initiative Study (WHI)
of 2002 showed that
women taking
synthetic estrogen combined
with synthetic progesterone have a higher incidence of
ovarian
cancer, breast cancer, stroke, and
heart
disease, with little evidence of osteoporosis reduction or
dementia prevention. WHI
researchers, who usually never make
recommendations except to
suggest more studies, advised doctors to
be very cautious about prescribing
HRT to their patients.(100,146-150)
Results of the
“Million
Women Study” on
HRT and
breast cancer in the UK
were published
in medical journal The
Lancet
in August 2003.
According to lead author Prof.
Valerie Beral, director
of the Cancer Research UK Epidemiology Unit:
"We estimate that
over the past decade, use
of HRT by UK
women aged 50-64
has resulted in an extra 20,000
breast cancers, estrogen-progestagen (combination) therapy accounting for 15,000 of
these.”(151) We
were unable to find statistics
on breast cancer, stroke, uterine cancer, or
heart disease caused by
HRT used by American women. Because the
US population
is roughly six times that of the
UK, it is possible that 120,000 cases of breast
cancer have been caused by
HRT in the past decade.
OFFICE OF TECHNOLOGY ASSESSMENT
(OTA)
Health Care
Technology
and Its Assessment in Eight Countries, 1995.
General Facts
1. In 1990,
US life expectancy was 71.8
years for men and 78.8 years
for women, among the lowest rates
in the
developed countries.
2. The 1990
US infant mortality rate in the
US was 9.2
per 1,000 live births, in the
bottom half of the distribution among all developed countries.
3.
Health status is correlated
with socioeconomic status.
4.
Health care is not universal.
5.
Health care is based on the free
market system with no
fixed budget or limitations on expansion.
6.
Health care accounts
for 14% of the
US GNP ($800 billion in
1993).
7. The federal government
does no central planning,
though it is the major
purchaser
of health care for older people
and some poor people.
8.
Americans are less
satisfied with their health care
system than people in other developed
countries.
9. US medicine specializes
in expensive medical technology; some large US cities
have more magnetic resonance image (MRI) scanners
than most countries.
10. Huge
public and private investments in medical research
and pharmaceutical development drive this
“technological arms race.”
11. Any efforts to
restrain
technological developments in health care
are opposed by
policymakers concerned about negative impacts on medical-technology industries.
Hospitals
1. In 1990,
the US had 5,480 acute-care hospitals, 880 specialty (psychiatric,
long-term care, and
rehabilitation)
hospitals, and 340 federal (military,
veterans, and Native American) hospitals,
or 2.7 hospitals per 100,000
population.
2.
In 1990, the average length
of stay for 33 million admissions
was 9.2 days. The bed occupancy
rate was 66%.
Lengths of stay were
shorter and admission rates lower than
other countries.
3. In 1990,
the US had 615,000 physicians, or
2.4
per 1,000 population; 33% were
primary care (family
medicine, internal medicine, and pediatrics) and 67%
were specialists.
4.
In 1991, government-run
health care spending
totaled $81 billion.
5. Total US
health care spending
rose to $752
billion in 1991 from
$70 billion in 1950.
Spending grew five-fold per
capita.
6.
Reasons for increased
healthcare spending include:
1.
The high cost of defensive
medicine, with an escalation
in services solely to
avoid malpractice litigation.
2. US health care
based on defensive medicine costs nearly
$45 billion per year, or
about 5% of total health care spending,
according to one source.
3. The availability
and use of new
medical
technologies have contributed the most to
increased health care
spending, argue many analysts. These
costs
are impossible to quantify.
7.
The reasons government attempts to control health
care costs
have failed include:
1. Market incentive and
profit-motive involvement in the
financing and organization
of health care, including
private insurers, hospital
systems, physicians, and the drug and
medical-device industries.
2.
Expansion is the goal of
free enterprise.
Health-Related Research and Development
1.
The US spends more than any
other country on
health-related
R&D.
2. In 1989,
the federal government spent $9.2 billion
on R&D, while private industry spent an
additional $9.4 billion.
3.
Total US R&D expenditures rose 50%
from 1983
to 1992.
4.
NIH receives about half of
US government
R&D funding.
5.
NIH spent more on
basic research ($4.1 billion in
1989) than for clinical
trials of medical treatments on humans
($519 million in
1989).
6. Most of
the clinical trials
evaluate new treatment protocols
for cancer and complications of
AIDS, and do
not study existing treatments, even though
their effectiveness is in many cases
unknown and questionable.
7.
In 1990, the NIH had just begun
to do
meta-analysis
and cost-effectiveness analysis.
Pharmaceutical and Medical-Device Industries
1.
About two-thirds of the industry's $9.4 billion
budget went to drug research; device
manufacturers spent the
remaining one-third.
2.
In addition to R&D, the medical
industry
spent 24% of total sales on
promoting their products
and 15% of total sales on development.
3.
Total marketing expenses in 1990 were
over $5 billion.
4.
Many products provide no
benefit over existing products.
5.
Public and private health care consumers
buy these
products.
6.
If health care spending is
perceived as a problem,
a highly profitable drug industry exacerbates
the problem.
Controlling Health Care
Technology
1.
The FDA ensures
the safety and efficacy of
drugs, biologics, and medical devices.
2. The
FDA does not consider costs of therapy.
3.
The FDA does not consider the
effectiveness of a therapy.
4.
The FDA does not compare a
product to currently
marketed products
5.
The FDA does not consider nondrug
alternatives for a given clinical problem.
6. It costs
$200 million in development costs to bring
a new drug to market. AIDS-drug interest groups forced new regulations
that speed up the approval
process.
7.
Such drugs should be
subject to greater post-marketing
surveillance requirements. As of 1995, these provisions had
not yet come into play.
8. Many argue that reductions
in the pre-approval testing of drugs open the
possibility of significant undiscovered toxicities.
Health Care
Technology
Assessment
1. Failure to
evaluate technology was a focus of
a 1978
report from OTA with
examples of many common
medical practices supported by limited published data
(10-20%).
2.
In 1978, Congress created the National
Center for Health Care Technology
(NCHCT) to advise Medicare and
Medicaid.
3. With an annual budget
of $4 million, NCHCT published three broad assessments
of high-priority technologies and made about
75 coverage recommendations to Medicare.
4.
Congress disbanded NCHCT in 1981. The
medical profession opposed it from the
beginning. The AMA testified
before Congress
in 1981 that “clinical policy analysis and judgments are better
made—and are being responsibly
made—within the medical
profession. Assessing risks and costs, as
well as benefits, has been
central to the
exercise of good medical judgment for
decades.”
5.
The medical device lobby also opposed
government
oversight by NCHCT.
Examples of
Lack of Proper
Management of HealthCare
Treatments for
Coronary
Artery Disease
1. Since the early 1970s,
the number of coronary artery bypass
surgeries
(CABGS) has risen rapidly without government regulation
or clinical
trials.
2. Angioplasty
for single vessel disease was
introduced in 1978.
The first published trial of
angioplasty versus medical treatment was done in
1992.
3.
Angioplasty did not reduce the number
of CABGS, as was promoted.
4.
Both procedures increase
in number every year as
the patient
population grows older and sicker.
5.
Rates of use
are higher in white patients and
private insurance
patients, and vary greatly by geographic region, suggesting
that
use of these procedures
is based on
non-clinical factors.
6. As of
1995, the
NIH consensus program had not
assessed CABGS since 1980 and
had never assessed
angioplasty.
7. RAND researchers evaluated
CABGS in New York in
1990.
They reviewed 1,300 procedures and
found 2%
were inappropriate, 90% were
appropriate, and 7% were uncertain. For
1,300
angioplasties, 4% were inappropriate and
38% uncertain.
Using RAND methodologies, a panel of
British physicians
rated twice as
many procedures “inappropriate” as
did a US panel rating the
same clinical
cases. The New York numbers are
in question because New York State
limits the number of
surgery centers, and the per-capita supply of cardiac
surgeons in New York
is about one-half of the national average.
8. The estimated five-year cost is
$33,000
for angioplasty and $40,000
for CABGS. Angioplasty did
not lower
costs, due to its high failure
rates.
Computed Tomography (CT)
1.
The first CT scanner in
the US was installed at
the Mayo Clinic in 1973.
By 1992, the number of
operational CT
scanners in the
US had grown to 6,060. By
comparison, in 1993
there were 216 CT units in
Canada
.
2.
There is little information available
on how CT scans improve or
affect patient
outcomes
3.
In some institutions, up to 90%
of scans performed were negative.
4. Approval
by the FDA was not required for
CT scanners, nor was any
evidence of safety or efficacy.
Magnetic Resonance Imaging (MRI)
1.
MRIs were introduced in Great Britain
in 1978 and
in the US in 1980. By
1988, there were 1,230 units and by
1992 between 2,800 and 3,000.
2. A definitive review
published in 1994
found less than 30 studies of
5,000 that were prospective comparisons of diagnostic accuracy or
therapeutic choice.
3.
The American College of Physicians
assessed MRI studies and rated 13 of 17 trials as
“weak,”
i.e., lacking data concerning therapeutic impact
or patient outcomes.
4.
The OTA concluded: “It is
evident that hospitals, physician-entrepreneurs, and
medical device manufacturers
have approached MRI and
CT as commodities with high-profit potential, and decision-making on the acquisition
and use of these procedures
has been highly influenced by this
approach. Clinical evaluation, appropriate patient
selection, and matching supply to
legitimate
demand might be viewed as
secondary forces.”
Laparoscopic Surgery
1.
Laparoscopic cholecystectomy was introduced at
a professional surgical society meeting in
late 1989.
By 1992,
85%
of all cholecystectomies were performed laparoscopically.
2.
There was an associated increase
of 30% in the number of
cholecystectomies performed.
3.
Because of the increased volume of
gall bladder operations,
their total cost increased
11.4% between 1988
and
1992, despite a 25.1% drop
in the average cost per
surgery.
4. The mortality rate for
gall bladder surgeries
did not decline as a
result of the lower risk because so
many more were
performed.
5.
When studies were finally done on
completed cases, the results showed
that
laparoscopic cholecystectomy was associated with
reduced inpatient duration, decreased pain, and a
shorter period of restricted activity. But rates
of bile duct and major vessel injury increased
and it was suggested that these rates
were worse for people with
acute cholecystitis. No clinical trials had
been done to clarify this issue.
6. Patient demand, fueled by substantial media
attention,
was a
major force in promoting rapid adoption
of these procedures.
7.
The major manufacturer of laparoscopic equipment
produced the video that
introduced the procedure in 1989.
8.
Doctors were given two-day
training seminars
before performing the surgery
on patients.
Infant Mortality
1.
In 1990, the US ranked 24th in
infant mortality of 38
developed countries with a
rate of 9.2
deaths per 1,000 live births.
2.
US black infant mortality is
18.6
per 1,000 live births, compared to
8.8 for whites.
Screening for
Breast Cancer
1.
Mammography screening
in women under 50 has always been
a subject of debate.
2. In 1992,
the Canadian National Breast Cancer
Study of 50,000
women showed that mammography had
no effect on mortality
for women aged 40-50.
3.
The National Cancer Institute (NCI) refused
to change its recommendations on mammography.
4.
The American Cancer Society
decided to wait for more
studies on mammography.
5. In December 1993, NCI
announced that women over 50
should have routine screenings every
one to two
years but that younger women would
derive no benefit from mammography.
Summary
1. The OTA
concluded:
“There are no
mechanisms in place to
limit dissemination of technologies regardless
of their clinical value.”
Shortly after the
release
of this report, the OTA
was disbanded.
Looking for a topic, use Google Internal Search Engine
INTERNAL SITE SEARCH ENGINE by Google
|
|